(Q42996525)

English

Partial depletion of tissue factor pathway inhibitor during subcutaneous administration of unfractionated heparin, but not with two low molecular weight heparins

scientific article published in December 1999

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Partial depletion of tissue factor pathway inhibitor during subcutaneous administration of unfractionated heparin, but not with two low molecular weight heparins (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1 reference

based on heuristic

inferred from title

Per Morten Sandset

5

object named as

Sandset PM

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

author name string

Bendz B

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hansen JB

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Andersen TO

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Ostergaard P

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

language of work or name

0 references

publication date

1 December 1999

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

107

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

756-762

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Anticoagulant effects of two types of low molecular weight heparin administered subcutaneously

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01791.X

21 January 2018

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01791.X

21 January 2018

Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01791.X

21 January 2018

Differential effect of unfractionated heparin and low molecular weight heparin on intravascular tissue factor pathway inhibitor: evidence for a difference in antithrombotic action

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01791.X

21 January 2018

The effect of protamine sulphate on plasma tissue factor pathway inhibitor released by intravenous and subcutaneous unfractionated and low molecular weight heparin in man.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01791.X

21 January 2018

Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01791.X

21 January 2018

An enzyme linked immunosorption assay for tissue factor pathway inhibitor.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01791.X

21 January 2018

Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01791.X

21 January 2018

Heparin induces release of extrinsic: Coagulation pathway inhibitor (EPI)

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01791.X

21 January 2018

Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01791.X

21 January 2018

Tissue factor pathway inhibitor in complex with low density lipoprotein isolated from human plasma does not possess anticoagulant function in tissue factor-induced coagulation in vitro

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01791.X

21 January 2018

Effect of Cholesterol Lowering on Intravascular Pools of TFPI and Its Anticoagulant Potential in Type II Hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01791.X

21 January 2018

Elevated TFPI in malignant disease: relation to cancer type and hypercoagulation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01791.X

21 January 2018

Binding of tissue factor pathway inhibitor to cultured endothelial cells-influence of glycosaminoglycans

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01791.X

21 January 2018

A sensitive assay of extrinsic coagulation pathway inhibitor (EPI) in plasma and plasma fractions

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01791.X

21 January 2018

Characterization of the binding between tissue factor pathway inhibitor and glycosaminoglycans

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01791.X

21 January 2018

Identifiers

10.1046/J.1365-2141.1999.01791.X

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42996525&oldid=1976294671"